© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
July 30, 2021
The FDA has issued a complete response letter regarding a new drug application for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
June 25, 2021
The mechanism of action of roxadustat differs from that of erythropoietin stimulating agents.
May 04, 2021
Lumasiran is the first drug approved by the FDA for the treatment of patients with primary hyperoxaluria type 1.
April 28, 2021
The application for the targeted release formulation of budesonide is supported by data from the phase 3 NefIgArd trial and the phase 2 NEFIGAN trial.
March 09, 2021
The retrospective study compared reintervention rates in the 4 standard surgical interventions for lower urinary tract symptoms due to benign prostatic obstruction.
January 18, 2021
Minimally-invasive treatment with the iTind device (Medi-Tate) provides rapid and sustained improvement of LUTS in men with BPH, without adversely affecting patients’ sexual function, according to a recently published 12-month study.
January 06, 2021
Lobe enucleation efficiency is significantly better with Moses technology, investigators report.
December 30, 2020
On the latest episode of the Speaking of Urology podcast, Dr. Giulia Lane discusses her recent study evaluating treatment of urethral stricture disease in women.
December 21, 2020
Compared with the open procedure, robot-assisted simple prostatectomy was associated with a shorter median hospital stay.
December 09, 2020
Experts in prostate cancer, bladder cancer, kidney stones, OAB/incontinence, BPH, and sexual dysfunction recap all the key advances from 2020.